Joan Stafslien's Net Worth
$7.99 Million
Who is Joan Stafslien?
Joan Stafslien has an estimated net worth of $7.99 Million. This is based on reported shares across multiple companies, which include Ra Medical Systems, Inc., CAREFUSION Corp, and NUVASIVE INC.
SEC CIK
Joan Stafslien's CIK is 0001467816
Past Insider Trading and Trends
2009 was Joan Stafslien's most active year for acquiring shares with 9 total transactions. Joan Stafslien's most active month to acquire stocks was the month of July. 2015 was Joan Stafslien's most active year for disposing of shares, totalling 15 transactions. Joan Stafslien's most active month to dispose stocks was the month of July. 2015 saw Joan Stafslien paying a total of $5,462,652.75 for 261,726 shares, this is the most they've acquired in one year. In 2015 Joan Stafslien cashed out on 646,037 shares for a total of $9,056,083.41, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Ra Medical Systems, Inc. (VTAK) Snapshot price: $0.402
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +90.70% | 4K |
—
|
—
| 8.41K |
Jun 4
| |||
Form 4
|
∞
| 4.41K |
$5.67 | $25,002.50 | 4.41K |
Nov 19
| |||
Form 4
| +400.00% | 100K |
—
|
—
| 125K |
Oct 12
| |||
Form 4
|
∞
| 25K |
—
|
—
| 25K |
Apr 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CAREFUSION Corp No price found
EVP, General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -93.56K |
—
|
—
|
0
|
Mar 17
| |||
Form 4
| +177.26% | 59.82K |
$42.79 | -$3,593,430.66 | 93.56K |
Mar 11
| |||
Form 4
| -17.39% | -7.11K |
$44.04 | -$735,071.64 | 33.75K |
Scheduled
|
Aug 15
| ||
Form 4
| +10.99% | 4.05K |
$42.90 | -$103,346.10 | 40.85K |
Aug 5
| |||
Form 4
|
—
|
0
|
$31.89 | -$528,406.72 | 36.8K |
Scheduled
|
May 16 - May 19
| ||
Form 4
| -24.59% | -12.00K |
$36.69 | -$595,600.54 | 36.8K |
Scheduled
|
Feb 19
| ||
Form 4
| +15.75% | 6.64K |
$36.98 | -$146,734.08 | 48.8K |
Aug 15 - Aug 16
| |||
Form 4
|
—
|
0
|
$28.18 | -$640,960.09 | 42.16K |
Scheduled
|
Apr 2
| ||
Form 4
|
—
|
0
|
$30.05 | -$3,765.80 | 42.16K |
Scheduled
|
Mar 28
| ||
Form 4
| -32.92% | -20.69K |
$25.22 | -$693,330.60 | 42.16K |
Feb 15
| |||
Form 4
| +20.81% | 10.83K |
$27.86 | -$174,793.64 | 62.85K |
Sep 15
| |||
Form 4
| +0.25% | 128 |
$22.09 | -$1,980.03 | 52.02K |
Aug 31
| |||
Form 4
| +9.69% | 4.58K |
$26.74 | -$71,084.42 | 51.9K |
Aug 15 - Aug 16
| |||
Form 4
| -4.26% | -2.10K |
$24.14 | -$463,608.70 | 47.31K |
Sep 15
| |||
Form 4
| +8.46% | 3.86K |
$25.57 | -$57,150.96 | 49.42K |
Aug 15 - Aug 16
| |||
Form 4
| +208.28% | 30.78K |
—
|
—
| 45.56K |
Aug 2
| |||
Form 4
| +254.24% | 10.61K |
$24.00 | -$155,856.00 | 14.78K |
Sep 15
| |||
Form 4
| +57.91% | 1.53K |
$22.85 | -$20,290.80 | 4.17K |
Aug 15 - Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 31 - Sep 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NUVASIVE INC No price found
EVP and General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
∞
| 5K |
$59.68 | $298,400.00 | 5K |
Oct 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||